Drug-Resistant Tuberculosis in High-Risk Groups, Zimbabwe

To estimate prevalence of multidrug-resistant tuberculosis (MDR TB) in Harare, Zimbabwe, in 2012, we performed microbiologic testing on acid-fast bacilli smear-positive sputum samples from patients previously treated for TB. Twenty (24%) of 84 specimens were consistent with MDR TB. A national drug-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Metcalfe, John Z., Makumbirofa, Salome, Makamure, Beauty, Sandy, Charles, Bara, Wilbert, Mungofa, Stanley, Hopewell, Philip C., Mason, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2014
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884722/
https://www.ncbi.nlm.nih.gov/pubmed/24377879
http://dx.doi.org/10.3201/eid2001.130732
Descripción
Sumario:To estimate prevalence of multidrug-resistant tuberculosis (MDR TB) in Harare, Zimbabwe, in 2012, we performed microbiologic testing on acid-fast bacilli smear-positive sputum samples from patients previously treated for TB. Twenty (24%) of 84 specimens were consistent with MDR TB. A national drug-resistance survey is needed to determine MDR TB prevalence in Zimbabwe.

Ejemplares similares